Feasibility and Acceptability of a Task-Shifted Intervention to Enhance Adherence to HIV Medication and Improve Depression in People Living with HIV in Zimbabwe, a Low Income Country in Sub-Saharan Africa
View/ Open
Author
Abas, Melanie
Nyamayaro, Primrose
Bere, Tarisai
Saruchera, Emily
Mothobi, Nomvuyo
Simms, Victoria
Mangezi, Walter
Macpherson, Kirsty
Croome, Natasha
Makadzange, Azure
Safren, Steven
Chibanda, Dixon
O’Cleirigh, Conall
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1007/s10461-016-1659-4Metadata
Show full item recordCitation
Abas, M., P. Nyamayaro, T. Bere, E. Saruchera, N. Mothobi, V. Simms, W. Mangezi, et al. 2017. “Feasibility and Acceptability of a Task-Shifted Intervention to Enhance Adherence to HIV Medication and Improve Depression in People Living with HIV in Zimbabwe, a Low Income Country in Sub-Saharan Africa.” AIDS and Behavior 22 (1): 86-101. doi:10.1007/s10461-016-1659-4. http://dx.doi.org/10.1007/s10461-016-1659-4.Abstract
Using a pilot trial design in an HIV care clinic in Zimbabwe, we randomised 32 adults with poor adherence to antiretroviral therapy and at least mild depression to either six sessions of Problem-Solving Therapy for adherence and depression (PST-AD) delivered by an adherence counsellor, or to Enhanced Usual Care (Control). Acceptability of PST-AD was high, as indicated by frequency of session attendance and through qualitative analyses of exit interviews. Fidelity was >80% for the first two sessions of PST-AD but fidelity to the adherence component of PST-AD dropped by session 4. Contamination occurred, in that seven patients in the control arm received one or two PST-AD sessions before follow-up assessment. Routine health records proved unreliable for measuring HIV viral load at follow-up. Barriers to measuring adherence electronically included device failure and participant perception of being helped by the research device. The study was not powered to detect clinical differences, however, promising change at 6-months follow-up was seen in electronic adherence, viral load suppression (PST-AD arm 9/12 suppressed; control arm 4/8 suppressed) and depression (Patient Health Questionnaire—4.7 points in PST-AD arm vs. control, adjusted p value = 0.01). Results inform and justify a future randomised controlled trial of task-shifted PST-AD.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758696/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:34868812
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)